The Role and Therapeutic Targeting of CCR5 in Breast Cancer
Open Access
Abstract
The G-protein-coupled receptor C-C chemokine receptor 5 (CCR5) functions as a co-receptor for the entry of HIV into immune cells. CCR5 binds promiscuously to a diverse array of ligands initiating cell signaling that includes guided migration. Although well known to be expressed on immune cells, recent studies have shown the induction of CCR5 on the surface of breast cancer epithelial cells. The function of CCR5 on breast cancer epithelial cells includes the induction of aberrant cell survival signaling and tropism towards chemo attractants. As CCR5 is not expressed on normal epithelium, the receptor provides a potential useful target for therapy. Inhibitors of CCR5 (CCR5i), either small molecules (maraviroc, vicriviroc) or humanized monoclonal antibodies (leronlimab) have shown anti-tumor and anti-metastatic properties in preclinical studies. In early clinical studies, reviewed herein, CCR5i have shown promising results and evidence for effects on both the tumor and the anti-tumor immune response. Current clinical studies have therefore included combination therapy approaches with checkpoint inhibitors.Keywords
Funding Information
- National Institutes of Health (R01CA132115, R21CA235139, R43HL164131, #W81XWH1810605)
- U.S. Department of War (R01CA132115, R21CA235139, R43HL164131, #W81XWH1810605)
This publication has 142 references indexed in Scilit:
- Cancer cell metabolism: implications for therapeutic targetsExperimental & Molecular Medicine, 2013
- The CCL5/CCR5 axis promotes metastasis in basal breast cancerOncoImmunology, 2013
- Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxiaCancer Science, 2012
- TGF-β-induced activation of mTOR complex 2 drives epithelial–mesenchymal transition and cell invasionJournal of Cell Science, 2012
- The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic ImplicationsThe American Journal of Pathology, 2011
- Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayJournal of Cell Biology, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- On the Origin of Cancer CellsScience, 1956